Meet Parmvir Bahia
Parmvir Bahia is a neuroscientist trained in pharmacology, founder of Artha Science Media, chief executive officer of Scientists Inc. and a member of the American Society for Biochemistry and Molecular Biology Science Outreach and Communication Committee.

What is your research focus?
The role of sensory nerves in respiratory diseases.
What is the broader impact of your work?
The vagus nerve is essential to respiratory, cardiovascular and digestive system function. Mapping its reach and studying its physiology is key to helping us understand what goes wrong in diseases ranging from asthma to heart disease.
What have you learned from your work that applies to the rest of your life?
One facet of science that we all experience, but don't talk enough about, is failure. I have had several experiments that resulted in dead ends, or worse sent a project down completely the wrong track due to one false result. We can find parallels in life outside the lab, and, while it's not easy to admit when you're wrong, I think it's an important part of learning and being better.
How has being a member of the ASBMB helped you along the way?
Due to a change in personal circumstances, I recently stepped away from the bench to focus on doing scicomm and outreach work full time. Serving on the SOCC and attending the annual meetings has given me so many incredible opportunities to meet people and learn about work that allowed me to make that switch. In short, I would say that being a member has been fundamental to my current career path.
What are you watching or reading outside of work?
I've just finished watching “David Attenborough: A Life on Our Planet.” And on a more lighthearted note: “Welcome to Wrexham” — an underdog story about a Welsh football team bought up by actors Rob McElhenney and Ryan Reynolds.
What music or podcasts have you been enjoying lately?
I'm living out my heyday listening to ‘90s bands from the north of England, including Elbow, The Stone Roses, Mansun and the Kaiser Chiefs. And I like The Bugle for an irreverent look at the news.
Watch the interview
Parmvir Bahia talks about her career in science outreach and the successes and challenges of a recent project designed to put the needs of sensory sensitive kids first. Through this work, Parmvir exemplifies what it means to work with a community instead of for a community. Her advice to outreach practitioners is to treat your outreach like you do your science: research, evaluate and iterate.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

How undergrad research catalyzes scientific careers
Undergraduate research doesn’t just teach lab skills, it transforms scientists. For Antonio Rivera and Julissa Cruz–Bautista, joining a lab became a turning point, fostering critical thinking, persistence and research identity.

Simcox and Gisriel receive mentoring award
They were honored for contributing their time, knowledge, energy and enthusiasm to mentoring postdocs in their labs.

ASBMB names 2025 Marion B. Sewer scholarship recipients
Ten undergraduates interested in biochemistry and molecular biology will each receive $2,000 toward their tuition and related educational costs.

Attie named honorary professor
This award includes $100,000 of research funding and recognizes faculty who have made major contributions to the advancement of knowledge through their research, teaching and service activities.

Meet the 2025 SOC grant awardees
Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.